Sort by
Refine Your Search
-
ability to work fluently through the medium of Welsh and to a high standard is a key requirement, and that applications therefore need to be submitted in Welsh. This is a fixed-term, full-time role until 31
-
working full-time. The Health Data Research (HDR) UK Medicines in Acute and Chronic Care Driver Programme is a UK-wide multidisciplinary collaboration of clinical, data and discovery scientists focussed
-
preGnancy hEalth aNd elevaTed heAt) at Swansea University. Funded by the Wellcome Trust, MAGENTA explores how heat exposure and climate change affect pregnancies health across our communities. This is a
-
of the techniques we use (for instance cryogenics, ultra-high vacuum and Labview) will be appreciated, though are not formal requirements. In addition to salary, there is an overseas allowance
-
paramedic science as well as other subject areas (preferably utilising innovative teaching methods such as high-fidelity simulation). The successful candidate will be given support to further their academic
-
working full-time. The Wellcome Trust funded MAGENTA (Maternal And preGnancy hEalth aNd elevaTed heAt) project at Swansea University, addresses a critical gap in understanding how climate-related factors
-
2025. Please note that you must be registered with the Nursing and Midwifery Council in the UK to apply for this role. The Wellcome Trust funded MAGENTA (Maternal And preGnancy hEalth aNd elevaTed heAt
-
analysing website usage and performance, managing web content, building pages in a CMS, and SEO. Experience with platforms such as GA4, Silktide, Hotjar Google Search Console, Looker Studio, Semrush
-
About The University Swansea University is a research-led university that has been making a difference since 1920. The University community thrives on exploration and discovery and offers the right balance of excellent teaching and research, matched by an enviable quality of life. Our stunning...
-
, significantly increasing lifetime CRC risk up to 90%, with a 63% cumulative risk by age 60. MAP patients are additionally at high-risk for duodenal cancer and other extra-colonic manifestations. The clinical